Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 22 of 22 publications.

Alexander K, Margulis AV, Foreman PK, Shediac R, Calingaert B, Harding A, Pladevall-Vila M, Landis S. Birth prevalence of phenylalanine hydroxylase deficiency: a systematic literature review and meta-analysis. Poster presented at the Virtual ICPE 2021 Conference; August 23, 2021.

Foreman PK, Margulis AV, Alexander K, Shediac R, Calingaert B, Harding A, Pladevall-Vila M, Landis S. Birth prevalence of phenylalanine hydroxylase deficiency: a systematic literature review and meta-analysis. Orphanet J Rare Dis. 2021 Jun 3;16(1):253. doi: 10.1186/s13023-021-01874-6

Gilsenan A, Fortuny J, Cainzos-Achirica M, Cantero OF, Flynn RWV, Garcia-Rodriguez L, Harding A, Kollhorst B, Karlsson P, Linner L, MacDonald TM, Odsbu E, Plana E, Ruigomez A, Schink T, Ziemiecki R, Andrews EB. Cardiovascular safety of prucalopride in patients with chronic constipation: a multinational population-based cohort study. Drug Saf. 2019 Oct;42(10):1179-90. doi: 10.1007/s40264-019-00835-0

Gilsenan A, Fortuny J, Cainzos-Achirica M, Cantero OF, Flynn RW, Garcia-Rodriguez L, Harding A, Kollhorst B, Karlsson P, Linner L, MacDonald TM, Odsbu I, Plana E, Ruigomez A, Schink T, Ziemiecki R, Andrews EB. Cardiovascular safety of prucalopride for chronic constipation: a multinational population-based cohort study. Presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):33. doi: 10.1002/pds.4864

Ritchey ME, Harding A, Hunter S, Peterson C, Sager PT, Kowey PR, Nguyen L, Thomas S, Cainzos-Achirica M, Rothman KJ, Andrews EB, Anthony MS. Cardiovascular safety during and after use of phentermine and topiramate. J Clin Endocrinol Metab. 2019 Feb 1;104(2):513-22. doi: 10.1210/jc.2018-01010

Gilsenan A, Harding A, Kellier-Steele N, Harris D, Midkiff K, Andrews E. The Forteo patient registry linkage to multiple state cancer registries: study design and results from the first 8 years. Osteoporos Int. 2018 Oct;29(10):2335-43. doi: 10.1007/s00198-018-4604-8

Ritchey ME, Hunter S, Peterson C, Nguyen L, Thomas S, Harding A, Andrews EB, Rothman KJ, Cainzos-Achirica M, Anthony MS. Cardiovascular safety of phentermine and topiramate in a United States claims database. Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):449. doi: 10.1002/pds.4629

Krohn K, Kellier-Steele N, Gilsenan A, Harding A, Andrews E. Forteo voluntary patient registry: 6-year progress on a prospective osteosarcoma surveillance study. Poster presented at the 22nd Annual Meeting of the International Society of Clinical Densitometry (ISCD); June 2016. Dublin, Ireland.

Harris D, Gilsenan A, Harding A, Andrews E, Kellier N, Masica D. Long-term cancer surveillance: five-year update for the Forteo Patient Registry Surveillance Study. Poster presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 2015. Boston, MA.

Harris DH, Gilsenan AW, Harding AA, DeGuire B, Andrews EB. Long-term cancer surveillance: five-year update for the Forteo Patient Registry data linkage study. Presented at the NAACCR 2015 Annual Conference; June 2015. Charlotte, NC. Previously presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management.

Harris DH, Gilsenan AW, Midkiff KD, Harding AA. Navigating the registry-specific approval process for a long-term drug safety surveillance study. Presented at the NAACCR - North American Association of Central Cancer Registries; June 2013.

Gilsenan A, Andrews EB, Calingaert B, Crozier DA, Vanderpuije A. Evaluation of current risk evaluation and mitigation strategies. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 16, 2009. Providence, RI.

Leiss JK, Lyden JT, Mathews R, Sitzman KL, Vanderpuije A, Mav D, Kendra MA, Klein C, Humphrey CJ. Blood exposure incidence rates from the North Carolina study of home care and hospice nurses. Am J Ind Med. 2009 Feb 1;52(2):99-104.

Lyden JT, Vanderpuije A, Leiss JK, Klein C, Mathews R, Kendra MA. Rates of exposure to patient blood among home care and hospice nurses (HHNs): results from the North Carolina study of home care and hospice nurses. Poster presented at the 135th Annual Meeting of the American Public Health Association; November 2007.

Mathews R, Leiss J, Vanderpuije A. Completion of high school among teenage mothers in North Carolina: a prospective study using maternally linked birth records. Poster presented at the 134th Annual Meeting of the American Public Health Association; November 2006.

Cuffee J, Hallfors D, Waller M, Vanderpuije A. Adolescent's perceptions of sexual intercourse and movement to first sexual experience. Poster presented at the Annual Meeting of the Society for Research in Child Development; April 2005.

Vanderpuije A, Hallfors D, Halpern C, Iritani B, Waller M. Revealing more factors in the hiv/sti risk among African American adolescents. Poster presented at the Annual Meeting of the Society for Prevention Research; May 2004.

Vanderpuije A, Hallfors D, Halpern C, Iritani B, Waller M. Another piece of the puzzle: revealing more factors in the hiv/sti risk among African American adolescents. Poster presented at the Annual National STD Prevention Conference; March 2004.

Iritani B, Hallfors D, Halpern CT, Hussey JM, Bauer D, Guo G, Cho H, Vanderpuije A. Racial/ethnic differences in sti/hiv risk: sex and substance use patterns among adolescents. Poster presented at the Annual Meeting of the American Public Health Association; November 2003.

Hallfors D, Halpern C, Bauer DJ, Guo G, Hussey JM, Cho H, Iritani B, Waller MW, Kaestle A, Vanderpuije A. Hiv in young adulthood: pathways and prevention. Presented at the Binational Workshop on Drug Abuse and Addiction; October 2003.

Hallfors D, Halpern CT, Bauer DJ, Iritani B, Waller MW, Hussey JM, Cho H, Guo G, Vanderpuije A. Examining sex and drug patterns for hiv prevention. Poster presented at the Annual Meeting of the Society for Prevention Research; June 2003.

Harp JB, Franklin D, Vanderpuije AA, Gimble JM. Differential expression of signal transducers and activators of transcription during human adipogenesis. Biochem Biophys Res Commun. 2001 Mar 1;281(4):907-12.